|
|
|
|
| LEADER |
00859nam a2200181Ia 4500 |
| 008 |
150624b xxu||||| |||| 00| 0 eng d |
| 020 |
|
|
|a 3540648895
|
| 020 |
|
|
|a 3540648895
|
| 082 |
|
|
|a 615.19
|
| 245 |
|
|
|a Metallopharmaceuticals 1:
|b DNA interactions /
|c edited by M. J. Clarke
|
| 260 |
|
|
|a Berlin :
|b Springer Publications,
|c 1999.
|
| 300 |
|
|
|a 199 p.
|
| 505 |
|
|
|a 1. Anticancer activity of cisplatin and related complexes 2. Development of an orally active platinum anticancer drug: JM216 3. Trans-platinum compounds in cancer therapy: largely unexplored strategy for identifying novel antitumor platinum drugs 4. Chemi
|
| 700 |
|
|
|a Clarke, M. J.
|e editor.
|
| 700 |
|
|
|a Sadler, P. J.
|e editor.
|
| 942 |
|
|
|c TXT
|
| 999 |
|
|
|c 51132
|d 51132
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_190000000000000_CLA_M
|7 0
|9 51110
|a UL
|b UL
|c ST1
|d 2012-10-27
|l 0
|o 615.19 CLA/M
|p 73817
|r 2012-10-27
|w 2012-10-27
|y TXT
|